In adults hospitalized with COVID-19, adding remdesivir to standard care did not reduce in-hospital mortality.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 35500262.
- Also identified by DOI 10.7326/J22-0025.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Ali K, Azher T, Baqi M, et al. <b>Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial.</b> CMAJ. 2022;194:E242-51. 35045989.
Medical subject headings
- COVID-19 Drug Treatment